Vivian Tsai

Cooley advised CinCor Pharma, a clinical-stage biopharmaceutical company, on its definitive agreement to be acquired by AstraZeneca. M&A partners Rama Padmanabhan and Rowook Park and corporate partners Div Gupta and Sarah Sellers led the Cooley team.

A Cooley team advised Horizon Therapeutics, a specialty biopharmaceutical company, on its agreement to be acquired by Amgen. The approximately $28 billion merger would represent the third-largest all-cash transaction in the pharmaceutical sector in history and the biggest healthcare deal of 2022.

Cooley is advising Turning Point Therapeutics, a leading precision oncology company, on its definitive agreement to be acquired by global biopharmaceutical company Bristol Myers Squibb. Lawyers Barbara Borden, Rowook Park, Charles Bair, Lindsey O’Crump, Vivian Tsai and Melissa Meza are leading the Cooley team advising Turning Point Therapeutics.

Cooley advised Japanese company Paidy, a two-sided payments platform and provider of buy now, pay later (BNPL) solutions, on its agreement to sell to PayPal for approximately $2.7 billion in cash. Lawyers Rama Padmanabhan, Patrick Loofbourrow, Rowook Park, Andrew Harline and Vivian Tsai led the US- and Asia-based Cooley team advising Paidy on the transaction, which highlights Cooley’s strong capability for executing complex, globally handled deals.